HIV News and Research

RSS

PETA announces $50,000 grant to explore the reasons for HIV vaccine research failures

PETA is pleased to announce that it will bankroll a $50,000 grant to fund a first-of-its-kind study to explore the exact reasons why attempts to develop a vaccine against HIV have failed to produce a viable one for humans.

8 May 2023

Neuropathic pain study uncovers pathophysiological mechanism and promising therapeutic target

Neuropathic pain -; abnormal hypersensitivity to stimuli -; is associated with impaired quality of life and is often poorly managed. Estimates suggest that 3 percent to 17 percent of adults suffer from neuropathic pain, including a quarter of people with diabetes and a third of people with HIV.

5 May 2023

NIH researchers gain new insights on rare immune deficiency

In an 11-year study, researchers at the National Institutes of Health have further characterized idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune diseases and cancers.

4 May 2023

Advancing the development of vaccines through recombinant technology

In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO at Sino Biological, about current developments in the field of vaccine development through recombinant techniques.

From Sino Biological Inc. 4 May 2023

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection

A retrospective cohort study comparing the clinical presentation and treatment outcomes of people with HIV and those without HIV who were treated with tecovirimat for confirmed mpox virus infection. The study found that HIV status did not seem to affect treatment outcomes.

4 May 2023

New approach for efficient engineering of cell and gene therapies

A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods.

28 Apr 2023

Is there an association between ABO and RhD blood groups and risk of HIV infection?

Researchers investigated the association between HIV and the ABO and RhD blood groups.

28 Apr 2023

Stigma can be the most difficult part of living with epilepsy

Stigma affects all aspects of epilepsy care, from diagnosis and treatment to nationwide legislation and budget allocations.

27 Apr 2023

As US life expectancy falls, experts cite the health impacts of incarceration

After spending 38 years in the Alabama prison system, one of the most violent and crowded in the nation, Larry Jordan felt lucky to live long enough to regain his freedom.

27 Apr 2023

Possible risk factors for brain aneurysm development in adults living with HIV

With advances in antiretroviral therapy (ART), outcomes for adults living with human immunodeficiency virus (ALWH) have largely improved, drastically decreasing the risk of death from opportunistic infections.

26 Apr 2023

Study finds HIV to be 2.5 times more frequent among mental health service users

New National Institute for Health and Care Research Maudsley BRC supported research has found HIV is 2.5 times more frequent in people who use mental health services than the general population in South London.

26 Apr 2023

US officials want to end the HIV epidemic by 2030. Many stakeholders think they won’t.

In 2018, Mike Ferraro was living on the street and sharing needles with other people who injected drugs when he found out he was HIV-positive.

24 Apr 2023

Study reveals alarming global burden of antimicrobial resistance in bacterial infections

The paper presents a systematic analysis of the global burden of bacterial antimicrobial resistance in 2019. The authors highlight the urgent need for action to address this growing public health threat.

23 Apr 2023

The maternal mortality sustainable development goals are unlikely to be met by 2050, study suggests

Study developed a Global Maternal Health microsimulation model to measure global maternal death incidence.

21 Apr 2023

The Biden administration vowed to be a leading voice on opioid settlements but has gone quiet

Early in President Joe Biden's tenure, his administration promised to play a key role in ensuring opioid settlement funds went toward tackling the nation's addiction crisis.

21 Apr 2023

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

UC Davis Health researchers have dosed the second participant in their clinical trial looking to identify a potential cure for HIV utilizing CAR T-cell therapy.

19 Apr 2023

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

A recent study reveals that DCAF1 is overexpressed and phosphorylates EZH2 in colon cancer cells.

18 Apr 2023

Unravelling the factors influencing host tropism of SARS-CoV-2-related bat coronaviruses

Researchers investigated the tropism of SC2r-CoVs infecting Rhinolophus bats.

18 Apr 2023

Researchers use a quick, portable process to produce promising virus-fighting protein

A multidisciplinary research team has produced a promising virus-fighting protein using a quick, portable process that could be easily deployed at the source of a future virus outbreak.

12 Apr 2023

Daily statin medication could improve cardiovascular outcomes in people with HIV

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

11 Apr 2023